Live feed06:00:00·23dPRReleasevia QuantisnowPersonalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026ByQuantisnow·Wall Street's wire, on your screen.PSNL· Personalis Inc.Health Care
